Tag: SPARC
SPARC signs LOI with UCSF & Tiller Therapeutics for pre-clinical oncology...
Asset developed in three-year partnership between SPARC and UCSF. SPARC to receive 55% equity in Tiller Therapeutic
Sun Pharma Advanced Research signs licensing deal with Biomodifying LLC
SPARC enters into a licensing agreement with Biomodifying to acquire exclusive rights for antibody against unique oncology target
Sun Pharma initiates Phase 2 clinical trial of Psoriasis drug
SCD-044 is also being evaluated in other autoimmune disorders and Phase 2 studies for other indications like atopic dermatitis, are also expected to be initiated soon......................
Sun Pharma seals US$ 145 million deal with SPARC over potential...
The two companies have announced a worldwide licensing agreement on the development and commercialization of SCD-044 which is being evaluated as a potential oral treatment for atopic dermatitis, psoriasis and other auto-immune disorders.............
Schrödinger & SPARC collaborate to accelerate neurodegeneration drug development program
Collaboration brings together Schrödinger’s in silico discovery capabilities with SPARC’s novel insights into CNS pathways to speed drug development..................